Cargando…
Overlap of immunotherapy-related pneumonitis and COVID-19 pneumonia: diagnostic and vaccine considerations
The clinically indistinguishable overlap between pneumonitis caused due to immune checkpoint inhibition (ICI) and pneumonia associated with COVID-19 has posed considerable challenges for patients with cancer and oncologists alike. The cancer community continues to face the challenges that lay at the...
Autor principal: | Abid, Muhammad Bilal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098953/ https://www.ncbi.nlm.nih.gov/pubmed/33931473 http://dx.doi.org/10.1136/jitc-2020-002307 |
Ejemplares similares
-
COVID-19 VACCINE-RELATED PNEUMONITIS
por: TSENG, CHENGTIN, et al.
Publicado: (2022) -
Considerations for mitigating COVID-19 related risks in schools
por: Gimma, Amy, et al.
Publicado: (2021) -
Early immunomodulators with CAR T-cell immunotherapy in the COVID-19 era
por: Abid, Muhammad Bilal
Publicado: (2022) -
COVID-19 vaccine trials: Duty of care and standard of prevention considerations
por: Singh, Jerome Amir
Publicado: (2020) -
The double burden of disease of COVID-19 in cardiovascular patients: overlapping conditions could lead to overlapping treatments
por: Gonzalez-Jaramillo, Nathalia, et al.
Publicado: (2020)